ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
1341 National Cancer Institute Html en Smokeless Tobacco and Cancer A fact sheet about the health risks associated with the use of smokeless tobacco.
tobacco cut size0.465919
NCI smoking cessation0.353151
safe level0.345736
oral tobacco0.470575
nicotine addiction0.363201
Human Services0.340767
Health State-of-the-Science conference0.343313
U.S. Department0.340786
tobacco-specific nitrosamines0.373338
tobacco fertilizer0.451995
advisory committee0.346137
powdered tobacco0.462627
Health Organization International0.342988
oral cancer0.332186
National Institutes0.343448
Watson C. Surveillance0.3381
Tobacco Control Monograph0.451686
moist snuff0.436686
precancerous white patches0.344838
International Agency0.339252
NCI’s Smoking0.334129
Tobacco Research0.437462
NCI fact sheet0.385333
lower lip0.34967
esophageal cancer0.332063
nicotine stays0.353085
Yes. All tobacco0.450832
National Cancer Institute0.373261
LiveHelp online chat0.341688
American snuff0.346643
polynuclear aromatic hydrocarbons0.347124
Eastern time0.340428
spitting tobacco0.470917
online text chat0.340605
polycyclic aromatic hydrocarbons0.346589
smokeless tobacco products0.615213
smokeless tobacco cause0.576883
Nicotine content0.350271
un-ionized nicotine0.348074
Surgeon General0.344959
smokeless tobacco0.995709
Yes. Smokeless tobacco0.55885
dry snuff0.363969
noncancerous oral conditions0.343638
NIH State-of-the-Science Panel0.338818
tobacco cause cancer0.483342
smoking cessation counselor0.38611
tobacco juices0.469352
harmful chemicals0.350583
CLICK HERE
1537 National Cancer Institute Html en Newcastle Disease Virus (PDQ®)–Health Professional Version Expert-reviewed information summary about the use of Newcastle disease virus (NDV) as a treatment for people with cancer.
metastatic tumor cells0.405592
tumor cell lines0.391976
human cancer cells0.50054
genetically engineered NDV0.389911
NDV oncolysates0.413317
autologous tumor vaccine0.41773
infected cells0.416882
historical control subjects0.398257
irradiated ESb cells0.39152
Cancer Res0.395898
disease virus therapy0.398313
virus-modified tumor cells0.412589
virus-modified autologous tumor0.394368
autologous tumor cell0.439505
patients0.465722
Natl Cancer Inst0.401926
human tumor cells0.440276
lytic strains0.409693
normal human cells0.424643
cell vaccines0.393769
et al.0.391296
autologous tumor cells0.542424
colorectal cancer patients0.390231
cancer cells0.51627
newcastle disease virus0.925041
primary tumor cells0.39623
PUBMED Abstract0.426283
disease virus vaccine0.404352
uninfected cancer cells0.394475
tumor cells0.60365
tumor cell vaccine0.404276
progeny virus particles0.393227
NDV0.533791
Abstract0.460011
human immune cells0.389104
autologous cells0.393227
NDV genetic material0.390979
nonlytic NDV strains0.407173
NDV-infected cancer cells0.395154
malignant melanoma patients0.394264
Human tumor cell0.388361
renal cell carcinoma0.423539
cells0.622446
main NDV proteins0.390649
ESb cells0.400925
NDV strains0.410203
regional lymph nodes0.425639
cancer0.567906
irradiated tumor cells0.398885
CLICK HERE
1649 National Cancer Institute Html en Aromatherapy and Essential Oils (PDQ®)–Patient Version Expert-reviewed information summary about the use of aromatherapy and essential oils to improve the quality of life of cancer patients.
PDQ Aromatherapy0.51751
cancer treatment0.518478
modern aromatherapy0.502296
certain essential oils0.545828
aromatherapy training0.496531
PDQ cancer information0.582174
Cancer Complementary0.49782
hormone -like effects0.496783
clinical trials0.646919
cancer information summary0.54045
aromatherapy massage0.496545
alternative cancer therapies0.488792
clinical trial0.515897
CAM cancer research0.479249
patients0.520207
cancer patients0.499565
Aromatherapy products0.529674
bergamot essential oil0.494855
literature discuss aromatherapy0.518185
NCI PDQ cancer0.50787
cancer information database0.486869
aromatherapy0.710126
international aromatherapy programs0.515466
Therapies Editorial Board0.490712
essential oils0.964677
cancer information0.591001
treatment0.540034
Complementary Therapies Editorial0.514222
Drug Administration0.547203
Cancer Information Specialist0.481775
Aromatherapy research0.515581
tree essential oils0.64448
Cancer Information Service0.537651
tree essential oil0.496279
Antibacterial essential oils0.531896
National Cancer Institute0.639762
alternative medicine0.561892
standard aromatherapy certification0.518782
term aromatherapy0.502247
orange essential oil0.494346
aromatherapy courses0.496618
tea tree0.549957
cancer clinical trials0.48888
alternative therapies0.505894
ginger essential oil0.493305
cancer information summaries0.487611
cancer0.667969
Holistic Aromatherapy0.506338
CLICK HERE
1661 National Cancer Institute Html en Antineoplastons (PDQ®)–Health Professional Version Expert-reviewed information summary about antineoplastons as a treatment for people with cancer.
various tumor suppressor0.673325
high-risk pediatric patients0.613742
cell lines0.732784
antineoplaston A10.0.614589
steady state concentration0.632482
mean steady state0.62987
stable disease0.629423
tumor suppressor genes0.670419
antineoplaston a100.785651
multiple brain metastases0.666381
clinical trials0.642258
cancer cell line0.621623
cancer information summary0.628466
highest tumor response0.628298
patients0.960903
cancer patients0.782838
average dose0.662612
human colon cancer0.66679
tumor progression0.629611
colon cancer cells0.664834
antineoplaston treatment0.679278
complete tumor response0.726436
metastatic brain tumor0.711993
study0.663173
neutrophil apoptosis0.623745
Human/Clinical Studies section0.637915
neoplastic cell lines0.689948
human blood0.654645
cancer cells0.75191
animal tumor systems0.612469
National Cancer Institute0.656232
tumor growth0.643714
breast cancer patients0.772855
partial tumor response0.663127
AS2-10.676129
antineoplaston therapy0.747438
white blood cell0.631532
antineoplaston A.0.675544
abnormal cells0.630356
human tumor tissue.0.623365
human urine0.617971
antineoplastons0.86378
experimental cancer therapy0.633011
chronic lymphocytic leukemia0.610232
tumor response0.767878
objective tumor response0.612044
naturally occurring biochemical0.637098
antineoplastons A100.665762
cancer0.805413
CLICK HERE
1688 National Cancer Institute Html en Cannabis and Cannabinoids (PDQ®)–Patient Version Expert-reviewed information summary about the use of Cannabis and cannabinoids in the treatment of cancer-related side effects, such as nausea and vomiting.
cancer treatment0.54874
PDQ Cannabis0.53541
PDQ cancer information0.561631
Cancer Complementary0.483651
cancer therapy0.493942
clinical trials0.738523
cannabinoid receptors0.573547
advanced cancer patients0.489779
U.S. Food0.49892
cancer information summary0.529639
National Institutes0.485607
alternative cancer therapies0.482187
clinical trial0.556349
cancer therapies0.496308
patients0.580973
cancer patients0.559766
Cannabis users0.54158
Investigational New Drug0.490753
NCI PDQ cancer0.493719
cancer information database0.48226
effects0.498728
cannabinoids0.769857
main active cannabinoid0.509915
treatment0.563891
breast cancer cells0.497802
Cannabis plant extract0.540785
United States0.581783
Cannabis plant0.559258
Complementary Therapies Editorial0.487662
Drug Administration0.596753
Cancer Information Specialist0.479354
cancer cells0.516435
Cancer Information Service0.529301
Cannabis extract0.551963
National Cancer Institute0.60295
studies0.507275
alternative medicine0.50524
pain relief0.516491
advanced cancer0.497262
approved research settings0.478938
cannabis0.903862
chemotherapy-related nausea0.514076
cancer cell death0.500487
medicinal Cannabis0.540165
cancer clinical trials0.488981
alternative therapies0.483937
cancer information summaries0.482387
cancer0.807964
CLICK HERE
1798 National Cancer Institute Html es Aflicción, duelo y manejo de la pérdida (PDQ®)–Versión para pacientes Informe revisado por expertos acerca de la aflicción, el duelo y los sentimientos de pérdida de los sobrevivientes de alguien que murió de cáncer. Se trata también la aflicción en los niños.
cope with grief0.320516
Helping Children0.322023
Dialogue Between Parent0.307208
Wolfelt A0.31079
Hemisphere Publishing Corporation0.30651
siguientes preguntas0.304497
Corr CA0.321186
aflicción anticipatoria0.975865
Do We Tell0.306573
baja autoestima0.304526
Aflicción normalLa0.370032
Aflicción crónica0.366865
Instituto Nacional0.309451
cansancio extremo0.305043
GP Putnam Sons0.306438
Mourning Children0.305247
familiar cercano0.304362
When Someone Dies0.30744
siguientes libros0.304582
Tiffault BW0.304106
años todavía0.304515
Help Children Participate0.307506
TCC ayuda0.305556
religión ayuda0.304338
muerte ayuda0.319844
desarrollo edad comprensión0.306829
Remember Someone You0.30677
muerte expresiones0.319738
PDQ Aflicción0.353557
conversación).El tratamiento0.305805
aflicción anticipatoria ayuda0.436499
Publishing Company0.310219
National Cancer Institute0.305834
anticipatoriaLa aflicción anticipatoria0.37147
siguientes riesgos0.304531
New York0.346791
Children Mourning0.305247
siguientes factores0.316168
Physician Data Query0.319434
Mínima reacción0.30471
Mountain Rainbow Publications0.306521
Talking About Death0.30672
Springer Publishing Company0.306508
Children Cope with0.321223
Parent Dies0.311854
Tenth Good Thing0.306668
Helping Children Cope0.321422
Helping Children Understand0.308268
Accelerated Development0.311496
CLICK HERE
1894 National Cancer Institute Html es Tratamiento del cáncer de pulmón de células no pequeñas (PDQ®)–Versión para pacientes Resumen de información revisada por expertos acerca del tratamiento del cáncer de pulmón de células no pequeñas.
radiocirugía estereotáctica0.521736
cuáles ganglios0.544229
estadio iv0.535294
pequeño corte0.516426
sustancia llamada fcev0.511226
faja ajustadora0.518847
pequeña cantidad0.570347
Silbido respiratorio0.522024
cáncer.ampliar broncoscopia0.521373
gen alk0.51503
cáncer.ampliar mediastinoscopía0.517089
células normales.ampliar exploración0.600106
cuerpo.ampliar radiografía0.522592
estadios ia0.514018
rayos x0.552576
estadio ib0.557189
estadio ia0.556394
enlace drugs approved0.531609
ondas sonoras0.51647
Non-Small Cell Lung0.531866
células t0.528626
vías respiratorias0.808836
carcinoma epidermoide0.525518
numerosos ensayos0.516625
pecho.ampliar biopsia0.526618
estadios iia0.515213
estadio iiia0.625519
determinadas células0.530359
antecedentes familiares0.518918
alta potencia0.516655
estadio iia0.557019
tirosina cinasa0.692486
Cell Lung Cancer0.531364
siguientes sitios0.51534
siguientes situaciones0.666362
ecografía ayuda0.515534
principal factor0.576142
áreas.ampliar biopsia0.52208
siguientes formas0.529859
bronquiolos.ampliar anatomía0.52368
siguientes sumarios0.532291
siguientes pruebas0.527678
vasos sanguíneos0.979174
CLICK HERE
2021 National Cancer Institute Html es Prevención del cáncer de cuello uterino (PDQ®)–Versión para pacientes Información revisada por expertos sobre los factores que pueden aumentar el riesgo de cáncer de cuello uterino y los enfoques que podrían ayudar a la prevención de esta enfermedad.
Visuals Online0.544747
PDQ Exámenes0.729141
Internet NCI0.599334
siguientes factores0.942852
voluntarios sanos0.571782
Physician Data Query0.821847
Estados Unidos0.732136
suficiente ejercicio0.608117
prevención revisa0.577919
PDQ Prevención0.648162
cuánto tiempo0.58363
National Cancer Institute0.579131
invasivo aumenta0.607513
siguientes riesgos0.566231
siguientes sumarios0.745167
Instituto Nacional0.648132
CLICK HERE
2050 National Cancer Institute Html es Análisis del antígeno prostático específico (PSA) Hoja informativa sobre la prueba del antígeno prostático específico (PSA) y los exámenes selectivos de detección para el cáncer de próstata, y clarifica los beneficios y limitaciones de dicha prueba.
posibles complicaciones0.529476
United States Preventive0.549836
hiperplasia prostática benigna0.569875
fusión génica tmprss2-erg0.5485
estudio plco0.535774
PLCO trials0.538088
eréctil o incontinencia0.532144
médico quizás0.54755
ng per milliliter0.54786
concentration-based assay0.526257
Pauler DK0.526835
structure-based isopsa assay0.54715
estudio clínico plco0.561758
tanta lentitud0.531594
posibles perjuicios0.59922
riesgos y beneficios0.531533
Servicios Preventivos0.526931
European Randomised Study0.54659
hiperplasia benigna0.602949
Preventive Health Services0.541802
llamadas isoformas0.529743
Screening Draft Recommendations0.555159
Hugosson J0.571924
espectro de  isoformas0.553214
Instituto Nacional0.525806
próstata en asociación0.528933
PSA quizás0.924082
posibles efectos0.527227
Internal Medicine0.527548
Services Task Force0.63375
among men with0.545229
estados benignos0.530298
agrandamiento benigno0.537792
PubMed Abstract0.784346
prostate cancer0.975142
estadio inicial quizás0.562336
obstante exámenes0.563732
New England Journal0.630867
Goodman PJ0.525307
de 1 muerte0.528041
Roobol MJ0.576631
pequeños tumores0.530536
Heijnsdijk EAM0.527351
Hafron JM0.526062
CLICK HERE
3454 National Cancer Institute Html es Grados de comprobación científica de los estudios de terapias integrales, alternativas y complementarias en seres humanos con cáncer (PDQ®)–Versión para profesionales de salud Información acerca de cómo evaluar la solidez de los datos probatorios obtenidos de los estudios de investigación sobre terapias integrales, alternativas y complementarias en seres humanos con cáncer.
Visuals Online0.6561
grupo control0.658003
Physician Data Query0.707803
distintos tipos0.676327
mejores casos—0.670195
valoración indirectos0.860816
tratamiento versus muerte0.748944
National Cancer Institute0.697449
personas ayuda0.673043
siguientes riesgos0.659857
mejores casos0.807578
versus muerte0.798627
Instituto Nacional0.960893
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.